SUPPORT for Patients and Communities Reauthorization Act of 2025

This law reauthorizes and modifies Department of Health and Human Services programs through fiscal year 2030 to address substance use disorders, mental health, and overdose prevention. It expands existing initiatives to include transportation services for individuals in recovery, resources for non-opioid overdose treatments, and cybersecurity protections for the National Suicide Prevention Lifeline. Additionally, the act establishes a federal work group on fentanyl contamination and directs a review of the scheduling for certain buprenorphine and naloxone products under the Controlled Substances Act.

This legislation affects individuals with substance use disorders, including pregnant and postpartum women, youth, and children experiencing psychological trauma. It also impacts health care providers, medical students, and first responders who receive training, loan repayments, or resources for overdose prevention. Additionally, community organizations, recovery housing providers, and the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support are affected by reauthorized grant programs and technical assistance.

• Reauthorization of substance use and mental health programs. The bill extends funding from FY2026 through FY2030 for various programs addressing substance use disorders, overdose prevention, recovery housing, and mental health training for medical students.
• Expansion of first responder and recovery support resources. The legislation modifies existing programs to allow first responders to purchase treatments for non-opioid overdoses and permits employment service programs to provide transportation for individuals in recovery.
• Establishment of a fentanyl contamination work group. The bill creates a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs to coordinate federal efforts regarding the presence of fentanyl in illicit substances.
• Cybersecurity protections for the National Suicide Prevention Lifeline. New requirements are established for the Department of Health and Human Services to protect the National Suicide Prevention Lifeline program from potential cybersecurity threats.
• Review of buprenorphine and naloxone scheduling. The Department of Health and Human Services must review and potentially revise the classification of approved products containing both buprenorphine and naloxone under the Controlled Substances Act.
• Authorization of regional technical assistance for recovery support. The bill provides temporary authorization for a regional technical assistance center to support the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.

The bill reauthorizes various grant and health programs for the period of fiscal years 2026 through 2030.

This bill reauthorizes and revises existing Department of Health and Human Services programs addressing substance use disorders and mental health, and it directs a review of the scheduling of certain buprenorphine and naloxone products under the Controlled Substances Act.

The bill aims to reauthorize and revise Department of Health and Human Services programs focused on addressing substance use disorders, overdoses, and mental health. It intends to support recovery, prevention, and treatment efforts through grant programs, workforce training, and new federal requirements for cybersecurity and interagency coordination on drug contamination.